[Chronic obstructive pulmonary disease and heart failure].
Villar Alvarez, Felipe
[Chronic obstructive pulmonary disease and heart failure]. [electronic resource] - Archivos de bronconeumologia Aug 2009 - 387-93 p. digital
Publication Type: Journal Article; Review
1579-2129
10.1016/j.arbres.2008.05.011 doi
Adrenergic beta-Agonists--adverse effects
Adrenergic beta-Antagonists--adverse effects
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Atrial Natriuretic Factor--blood
Biomarkers
Bronchodilator Agents--adverse effects
C-Reactive Protein--analysis
Combined Modality Therapy
Contraindications
Drug Interactions
Heart Failure--blood
Heart Function Tests
Humans
Hypertension, Pulmonary--drug therapy
Natriuretic Peptide, Brain--blood
Oxygen Inhalation Therapy
Peptide Fragments--blood
Pulmonary Disease, Chronic Obstructive--blood
Pulmonary Heart Disease--drug therapy
Respiration, Artificial
Respiratory Function Tests
[Chronic obstructive pulmonary disease and heart failure]. [electronic resource] - Archivos de bronconeumologia Aug 2009 - 387-93 p. digital
Publication Type: Journal Article; Review
1579-2129
10.1016/j.arbres.2008.05.011 doi
Adrenergic beta-Agonists--adverse effects
Adrenergic beta-Antagonists--adverse effects
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Atrial Natriuretic Factor--blood
Biomarkers
Bronchodilator Agents--adverse effects
C-Reactive Protein--analysis
Combined Modality Therapy
Contraindications
Drug Interactions
Heart Failure--blood
Heart Function Tests
Humans
Hypertension, Pulmonary--drug therapy
Natriuretic Peptide, Brain--blood
Oxygen Inhalation Therapy
Peptide Fragments--blood
Pulmonary Disease, Chronic Obstructive--blood
Pulmonary Heart Disease--drug therapy
Respiration, Artificial
Respiratory Function Tests